MDT

95.97

-0.18%↓

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

Начало・Списък с акции・Vaxart Inc

Vaxart Inc

Затворен

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

Максимум

Ключови измерители
By Trading Economics
Приходи	6.8M -8.1M
Продажби	33M 72M
EPS	-0.04
Марж на печалбата	-11.242
Служители	105
EBITDA	6.7M -5.4M

Дивиденти
By Dow Jones
Следващи печалби	19.03.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-7.3M 84M
Предишно отваряне	0
Предишно затваряне	0

Техническа оценка

By Trading Central

Увереност

Bearish Evidence

0.4007 / 0.4252 Подкрепа & съпротива

Vaxart Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

2.01.2026 г., 22:45 ч. UTC

Значими двигатели на пазара

GH Research Shares Up, Plans to Provide Update on New Drug Application

2.01.2026 г., 22:13 ч. UTC

Пазарно говорене

Печалби

Tesla Seen As Quiet on Artificial-Intelligence Efforts -- Market Talk

2.01.2026 г., 21:50 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Tech, Media & Telecom Roundup: Market Talk

2.01.2026 г., 21:50 ч. UTC

Пазарно говорене

Auto & Transport Roundup: Market Talk

2.01.2026 г., 21:07 ч. UTC

Печалби

Tesla Stock Pops and Drops After Fourth-Quarter Deliveries. -- Barrons.com

2.01.2026 г., 20:09 ч. UTC

Пазарно говорене

Oil Futures Slip in First Trading Day of the Year -- Market Talk

2.01.2026 г., 19:48 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Kick Off 2026 With A Loss -- Market Talk

2.01.2026 г., 18:53 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

2.01.2026 г., 18:53 ч. UTC

Пазарно говорене

Mexico PMIs Show Manufacturing Weakness in December -- Market Talk

2.01.2026 г., 17:56 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Meta's Manus Acquisition May Help Fill AI Monetization Gap -- Market Talk

2.01.2026 г., 17:50 ч. UTC

Пазарно говорене

Apparel Industry Seen With Strength Across Income Levels -- Market Talk

2.01.2026 г., 17:20 ч. UTC

Пазарно говорене

Auto & Transport Roundup: Market Talk

2.01.2026 г., 16:33 ч. UTC

Пазарно говорене

Remittances to Mexico Fell 5.7% in November -- Market Talk

2.01.2026 г., 16:18 ч. UTC

Пазарно говорене

Tesla Dethroned as World's Largest EV Maker -- Market Talk

2.01.2026 г., 15:48 ч. UTC

Печалби

Software Has Been Battered by AI. Shopify, Veeva, and 3 More Stocks to Play a Turnaround. -- Barrons.com

2.01.2026 г., 15:17 ч. UTC

Пазарно говорене

Tesla Expected to Make Its Switch to Robotics, AI in 2026 -- Market Talk

2.01.2026 г., 15:01 ч. UTC

Пазарно говорене

Sable Seen Nearing Production Relaunch After Court Ruling -- Market Talk

2.01.2026 г., 15:00 ч. UTC

Печалби

The Maker of Biscoff Cookies Bets on a Global Expansion -- WSJ

2.01.2026 г., 14:56 ч. UTC

Пазарно говорене

Tesla's Sales Drop Was Better Than Feared -- Market Talk

2.01.2026 г., 14:20 ч. UTC

Пазарно говорене

Capstone Copper's Mantoverde Strike Could Be Costly -- Market Talk

2.01.2026 г., 14:20 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

2.01.2026 г., 14:13 ч. UTC

Пазарно говорене

Oil Futures Open Year Lower on Oversupply Concerns -- Market Talk

2.01.2026 г., 13:39 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Open Year Lower -- Market Talk

2.01.2026 г., 13:01 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Unicredit Could Buy Delfin's BMPS Stake, Launch Full Takeover, Equita Says -- Market Talk

2.01.2026 г., 12:45 ч. UTC

Пазарно говорене

Emerging-Market Dollar Bonds Record Strong Returns in 2025 -- Market Talk

2.01.2026 г., 11:48 ч. UTC

Пазарно говорене

European Gas Climbs as Cold Weather Bites -- Market Talk

2.01.2026 г., 11:36 ч. UTC

Пазарно говорене

Treasury Yields, Dollar Edge Higher as Near-Term Fed Rate Cut Looks Unlikely -- Market Talk

2.01.2026 г., 11:30 ч. UTC

Пазарно говорене

Copper Rally Continues, Spurred by Supply Shocks -- Market Talk

2.01.2026 г., 11:29 ч. UTC

Пазарно говорене

Dollar Rises After Posting Worst Year Since 2017 -- Market Talk

2.01.2026 г., 11:15 ч. UTC

Пазарно говорене

Global Energy Roundup: Market Talk

Сравнение с други в отрасъла

Ценова промяна

Vaxart Inc Прогноза

Консенсусна оценка

By TipRanks

0 ratings

Купи

Задържане

Продай

Според 0 анализатори, дали борсови рейтинги на Vaxart Inc през последните 3 месеца.

Техническа оценка

By Trading Central

0.4007 / 0.4252Подкрепа & съпротива

Recent bearish events outweigh bullish events.

There is one bearish event.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Vaxart Inc

Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII.4 norovirus strains; coronavirus vaccine, which is in Phase 2 clinical trial, for the treatment of SARS-CoV-2 infection; seasonal influenza vaccine, which is in Phase 2 clinical trial, to treat H1 influenza infection; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.